Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1466]

EHA 2014: Retrospective analysis of overall survival adjusting for patient crossover in phase III of pomalidomide in previously treated multiple myeloma

EHA 2014: Retrospective analysis of overall survival adjusting for patient crossover in phase III of pomalidomide...

Ultraviolet radiation targets TP53 to accelerate BRAF-driven melanoma development

Ultraviolet radiation targets TP53 to accelerate BRAF-driven melanoma development

Provectus outlines path forward for PV-10

Provectus outlines path forward for PV-10

Five or more blistering sunburns before age twenty may increase melanoma risk by eighty percent

Five or more blistering sunburns before age twenty may increase melanoma risk by eighty percent

ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma

ASCO 2014: PD-1 targeting immunotherapy MK-3475 has high and long-lasting activity against metastatic melanoma

ASCO 2014: Ipilimumab with nivolumab achieves long-term survival in advanced melanoma

ASCO 2014: Ipilimumab with nivolumab achieves long-term survival in advanced melanoma

ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma

ASCO 2014: Adjuvant ipilimumab improves recurrence-free survival in high-risk melanoma

Researchers discover new way to combat drug resistance in skin cancer

Researchers discover new way to combat drug resistance in skin cancer

PV-10 data for break through therapy designation application highlighted by ASCO

PV-10 data for break through therapy designation application highlighted by ASCO

Promising combination treatment demonstrates safety and tolerability in patients with most aggressive form of skin cancer

Promising combination treatment demonstrates safety and tolerability in patients with most aggressive form of skin...

More from ecancer